Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AbbVie, Nimble
AbbVie to acquire Nimble Therapeutics for $200m
The acquisition includes Nimble's investigational candidate, an oral peptide IL23R inhibitor to treat psoriasis.
ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline
AbbVie ABBV announced that it has entered into a definitive agreement to acquire privately held biotech, Nimble Therapeutics. The impending acquisition will add Nimble’s lead preclinical asset and a pipeline of other novel oral peptide candidates with potential across several autoimmune diseases to AbbiVie’s Immunology pipeline.
AbbVie buys Roche spinout Nimble Therapeutics for $200M
AbbVie is paying $200 million to snap up Nimble Therapeutics, a Roche spinout working to develop oral peptide treatments in the autoimmune space. | AbbVie is paying $200 million to snap up Nimble Therapeutics,
AbbVie To Acquire Nimble Therapeutics For $200 Mln In Cash
Friday announced an agreement to acquire Nimble Therapeutics for a cash payment of $200 million at closing, along
AbbVie Buying Nimble Therapeutics for $200M to Boost Immunology Pipeline
AbbVie has agreed to buy privately held biotechnology company Nimble Therapeutics for $200 million in cash in a deal that bolsters the biopharmaceutical company's expansive immunology portfolio.
AbbVie Stock Volatile On $200M Deal To Buy Nimble Therapeutics: Retail Still Bearish
Shares of AbbVie Inc. oscillated between gains and losses Friday as the company’s latest acquisition drew mixed reactions from investors. AbbVie announced a $200 million deal to acquire Nimble Therapeutics,
BioPharma Dive
3d
AbbVie to acquire Roche spinout Nimble in immune drug deal
The pharma will pay $200 million to buy Nimble and a preclinical oral drug that blocks a protein known as IL-23 — the target ...
Crain's Chicago Business
3d
AbbVie to acquire Wisconsin biopharma for $200 million
Buying Nimble Therapeutics represents AbbVie's latest deal to build out a pipeline in the wake of fading sales of its once ...
Yahoo Finance
13d
Nimble Introduces Qi2 Wireless Charging Collection - Available at Apple
Nimble
PODIUM 3-in-1 Wireless Charger
Nimble
PODIUM 3-in-1 Wireless Charger. Power three devices at once.
Nimble
VALET 3-in-1 Wireless Charger
Nimble
VALET 3-in-1 Wireless Charger. Features a ...
5d
Nimble Fold 3-in-1 Wireless Charger Review: A Modern Traveling Solution
Nimble sells the Fold 3-in-1 Wireless Charger exclusively through the Apple Store, both online and in person. It comes in ...
The Business Journals
4d
AbbVie to buy Madison pharmaceutical tech firm for $200 million
Pharmaceutical giant AbbVie Inc. has agreed to acquire Madison's
Nimble
Therapeutics Inc. for $200 million in cash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback